How to taper doxepin (tricyclic antidepressant)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Taper Doxepin (Tricyclic Antidepressant)

Taper doxepin by reducing the dose by 10% of the previous dose every 2-4 weeks, extending to 10% per month for patients on long-term therapy, continuing down to very small final doses before complete cessation to minimize withdrawal symptoms.

Recommended Tapering Protocol

Start with a 10% reduction of the most recent dose (not the original dose) every 2-4 weeks. 1 This hyperbolic tapering approach—where each reduction is 10% of the current dose rather than the original dose—results in progressively smaller absolute dose decrements as you approach discontinuation. 2

Specific Tapering Strategy

  • For short-term use (months): Reduce by 10% of the previous dose every 2-4 weeks 1
  • For long-term use (years): Slow to 10% reductions per month or even slower 1, 3
  • Example for 100mg daily:
    • First reduction: 90mg (10% reduction) 1
    • Second reduction: 81mg (10% of 90mg) 1
    • Third reduction: 73mg (10% of 81mg)
    • Continue this pattern down to very small doses

Critical Final Dosing Considerations

Do not stop at the lowest commercially available dose. The final doses before complete cessation may need to be as small as 1/40th of a therapeutic dose to prevent large receptor changes when stopped. 4 This hyperbolic tapering method reduces the biological effect at receptors by fixed amounts, minimizing withdrawal. 2

Monitoring and Adjustment

Monitor for withdrawal symptoms after each dose reduction before proceeding to the next step. 1 Tricyclic antidepressant withdrawal symptoms include anxiety, insomnia, flu-like symptoms, nausea, headache, and mood changes. 1

If Withdrawal Symptoms Emerge

  • Pause the taper and maintain the current dose until symptoms resolve 3
  • Return to the previous well-tolerated dose if symptoms are severe 1, 5
  • Slow the taper further by extending time between reductions or making smaller decrements 5
  • Tapers may need to be paused and restarted when the patient is ready 3

Timeline Expectations

The taper will likely take 6-12 months minimum, possibly longer for patients on doxepin for years. 3 Tapers are considered successful as long as the patient is making progress—durability matters more than speed. 3

Extending the Interval Method

Once you reach the smallest dose you can practically administer, extend the interval between doses rather than continuing to reduce the dose. 3 For example, transition from daily dosing to every other day, then every third day, before complete cessation.

Managing Withdrawal Symptoms

If withdrawal symptoms occur despite gradual tapering:

  • For insomnia: Short-term trazodone 3
  • For increased sympathetic activity: α2-adrenergic agonists like clonidine 1
  • For muscle aches: Acetaminophen or NSAIDs 1

Special Populations

For elderly patients: Use more gradual tapers with smaller dose reductions, as they face particular risks from tricyclic antidepressants including cognitive impairment and fall risk. 3

For pregnant patients: Do not taper during pregnancy without specialist consultation. 3

Critical Pitfalls to Avoid

  • Never taper too quickly (faster than 10% every 2-4 weeks for short-term use, or 10% per month for long-term use) 1, 3
  • Never set arbitrary time limits for completing the taper; individualize based on patient response 1, 5
  • Never abandon the patient during the tapering process; ensure continued support and monitoring 3, 1
  • Never abruptly discontinue except in cases of serious medical toxicity 1

Follow-Up Schedule

Follow up at least monthly during the taper, with more frequent contact during difficult phases. 3 Set clear expectations with patients about the tapering process and potential withdrawal symptoms. 1

When to Refer to a Specialist

Refer patients with:

  • History of withdrawal seizures 3
  • Unstable psychiatric comorbidities 3
  • Co-occurring substance use disorders 3
  • Previous unsuccessful tapering attempts 3

References

Guideline

Tapering Zoloft (Sertraline) Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tapering Protocol for Mirtazapine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.